covid-19 y el sistema renina, angiotensina, aldosterona. una relaci√≥n compleja covid-19 and the renin, angiotensin, aldosterone system. a complex relationship. Copyright: ¬© 2020 Permanyer.The COVID-19 pandemic has had major negative health, psychological, social and economic repercussions for individuals, families, communities, countries and for humanity in general. The interrelation with age and the presence of chronic non-communicable diseases (hypertension, diabetes, obesity, smoking) seems to go further than what would be explained by the prevalence and distribution of both. The drugs that act on the renin-angiotensin-aldosterone system are in many cases the backbone for the management of these diseases, it has been known for a long time that these drugs significantly increase the expression of receptors for angiotensin conversion enzyme type 2 in the lung tissue. This fact, together with the knowledge that the route of entry of the virus into the cell is precisely the ACE-2 receptor, initiated a hypothesis, based on very low-quality evidence, which quickly became generalized in the media, that the use of these drugs could be negative and that they should be interrupted immediately. The response of practically all Scientific Societies was almost immediate, with the precise indication that treatment with these drugs should not be discontinued, since the evidence of their usefulness is based on very solid and high-quality evidence. Simultaneously, a different hypothesis also appeared, also based on very preliminary evidence, that these drugs are not only harmful but also beneficial, however these medicaments are not yet accepted as agents for the prevention or treatment of this disease or its complications. This review reports current knowledge on the relationship between COVID-19 and SRAA.La pandemia por COVID-19 ha tenido muy importantes repercusiones negativas, sanitarias, psicol√≥gicas, sociales y econ√≥micas para las personas, las familias, las comunidades, los pa√≠ses y para las para la humanidad en general. La interrelaci√≥n con la edad y la presencia de enfermedades cr√≥nicas no trasmisibles (hipertensi√≥n, diabetes, obesidad, tabaquismo) parece ir mas lejos que lo que explicar√≠a la prevalencia y distribuci√≥n de ambas. Los medicamentos que act√∫an sobre el sistema renina-angiotensina-aldosterona, son pilares b√°sicos en el manejo de estas enfermedades. Se sabe de tiempo atr√°s que estos f√°rmacos aumentan en forma significativa la expresi√≥n en el tejido pulmonar de receptores para la enzima de conversi√≥n de angiotensina de tipo 2. Este hecho junto con el conocimiento de que la v√≠a de entrada del virus a la c√©lula es precisamente el receptor de ECA-2, inici√≥ una hip√≥tesis, basada en evidencia de muy baja calidad, que r√°pidamente se generaliz√≥ en los medios de comunicaci√≥n, de que el empleo de estos medicamentos podr√≠a ser negativo y que deber√≠an suspenderse. La respuesta de pr√°cticamente todas las sociedades cient√≠ficas fue casi inmediata, con la indicaci√≥n precisa de que no deber√≠a suspenderse el tratamiento con estos f√°rmacos, puesto que la evidencia de su utilidad est√° basada en una evidencia muy s√≥lida y de gran calidad. Casi simult√°neamente tambi√©n apareci√≥ la hip√≥tesis, tambi√©n basada en evidencia muy preliminar, de que estos medicamentos no solo resultan da√±inos sino que son ben√©ficos, tampoco se aceptan todav√≠a como agentes para la prevenci√≥n o tratamiento de esta enfermedad o sus complicaciones. La presente revisi√≥n relata los conocimientos actuales sobre la relaci√≥n entre COVID-19 y SRAA.